Tirzepatide, a promising new medication for people with type 2 diabetes, has been making waves in the pharmaceutical industry since its approval by the US Food and Drug Administration (FDA) in March 2021
We look at appetite, metabolism, hormone patterns, blood sugar, lifestyle, tolerance and sustainability
When injecting a semaglutide in the stomach pick a spot approximately two inches from the belly button
Tirzepatide targets two receptor pathways - GLP-1 and GIP - which appear to amplify appetite suppression
Most patients can begin Mounjaro the day after their last Saxenda dose
Allergic Reactions : Although rare, allergic reactions can occur with semaglutide